MSLN and ovarian cancer: According to in vitro killing assays, the developed CAR-Ts mediated strong tumoricidal effects against the murine ovarian cancer cell line Defb29 engineered to express human mesothelin, as it was reported that CAR expression rate grew low within a week following in vitro cultivation with a possible correlation with CAR-T expansion (141).